AGP Executive Report
Last update: 6 hours agoHospice exit: Humana signed a deal to sell its remaining minority stake in Gentiva, valuing it at about $900M, as the insurer completes its exit from hospice and palliative care; the sale is expected to close in Q3 2026 pending approvals. Drug safety: The FDA announced a recall of duloxetine bottles due to a potentially cancer-causing impurity above safety limits, warning that long-term exposure to nitrosamine impurities may raise cancer risk. Food & environment: A new review links the insecticide chlorpyrifos to multi-organ damage and chronic disease, prompting renewed EPA reassessment of whether it should stay approved for major crops. Brain health: A large Japanese study found drinking green tea (around three cups daily) was linked to fewer dementia-related brain lesions, with benefits not seen in everyone. AI in healthcare: Doctors warn AI chatbots can sound confident while giving wrong or incomplete medical advice, urging people not to replace clinicians. Community care: RWJBarnabas Health and Union County are launching a mobile pediatric unit to bring screenings, vaccines, and preventive care to underserved neighborhoods. Medication aftercare: Coverage on life after stopping Ozempic highlights common rebound weight gain and the need for support and healthy habits.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![CoreGLP Avis [DE, AT, CH, FR, BE, DK, FI, SE, NL] – The Truth Behind the Wellness Supplement Generating Buzz in 2026](https://ml.globenewswire.com/media/d3c5684a-11d1-4b14-a803-0e0b24cd5254/medium/coreglp.jpg)
